BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26586210)

  • 1. The oxytocin receptor antagonist, Atosiban, activates pro-inflammatory pathways in human amnion via G(αi) signalling.
    Kim SH; MacIntyre DA; Hanyaloglu AC; Blanks AM; Thornton S; Bennett PR; Terzidou V
    Mol Cell Endocrinol; 2016 Jan; 420():11-23. PubMed ID: 26586210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium.
    Kim SH; Pohl O; Chollet A; Gotteland JP; Fairhurst AD; Bennett PR; Terzidou V
    Mol Pharmacol; 2017 Apr; 91(4):403-415. PubMed ID: 28188254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin activates NF-κB-mediated inflammatory pathways in human gestational tissues.
    Kim SH; MacIntyre DA; Firmino Da Silva M; Blanks AM; Lee YS; Thornton S; Bennett PR; Terzidou V
    Mol Cell Endocrinol; 2015 Mar; 403():64-77. PubMed ID: 25451977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F
    Kim SH; Riaposova L; Ahmed H; Pohl O; Chollet A; Gotteland JP; Hanyaloglu A; Bennett PR; Terzidou V
    Sci Rep; 2019 Apr; 9(1):5792. PubMed ID: 30962532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.
    Engstrøm T; Bratholm P; Vilhardt H; Christensen NJ
    Biol Reprod; 1999 Feb; 60(2):322-9. PubMed ID: 9915997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
    Wrzal PK; Devost D; Pétrin D; Goupil E; Iorio-Morin C; Laporte SA; Zingg HH; Hébert TE
    Cell Signal; 2012 Jan; 24(1):342-50. PubMed ID: 21963428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of PKA-dependent and lipid-raft independent stimulation of Connexin43 expression by oxytoxin in mouse embryonic stem cells.
    Yun SP; Park SS; Ryu JM; Park JH; Kim MO; Lee JH; Han HJ
    Mol Endocrinol; 2012 Jul; 26(7):1144-57. PubMed ID: 22564436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.
    Zhong M; Yang M; Sanborn BM
    Endocrinology; 2003 Jul; 144(7):2947-56. PubMed ID: 12810550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism.
    Reversi A; Rimoldi V; Marrocco T; Cassoni P; Bussolati G; Parenti M; Chini B
    J Biol Chem; 2005 Apr; 280(16):16311-8. PubMed ID: 15705593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of oxytocin receptor gene expression in rabbit amnion cells.
    Jeng YJ; Lolait SJ; Soloff MS
    Endocrinology; 1998 Aug; 139(8):3449-55. PubMed ID: 9681495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions between the oxytocin receptor and the β2-adrenergic receptor: implications for ERK1/2 activation in human myometrial cells.
    Wrzal PK; Goupil E; Laporte SA; Hébert TE; Zingg HH
    Cell Signal; 2012 Jan; 24(1):333-41. PubMed ID: 21964067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of interleukin-1beta on oxytocin signalling in primary cells of human decidua.
    Friebe-Hoffmann U; Baston DM; Hoffmann TK; Chiao JP; Rauk PN
    Regul Pept; 2007 Aug; 142(3):78-85. PubMed ID: 17428554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary mechanisms of enhanced oxytocin-stimulated prostaglandin E2 synthesis in rabbit amnion at the end of gestation.
    Jeng YJ; Liebenthal D; Strakova Z; Ives KL; Hellmich MR; Soloff MS
    Endocrinology; 2000 Nov; 141(11):4136-45. PubMed ID: 11089546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin hyperpolarizes cultured duodenum myenteric intrinsic primary afferent neurons by opening BK(Ca) channels through IP₃ pathway.
    Che T; Sun H; Li J; Yu X; Zhu D; Xue B; Liu K; Zhang M; Kunze W; Liu C
    J Neurochem; 2012 May; 121(4):516-25. PubMed ID: 22356163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of oxytocin receptors in rabbit amnion by adenosine 3',5'-monophosphate.
    Hinko A; Soloff MS
    Endocrinology; 1993 Jan; 132(1):126-32. PubMed ID: 8380370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mechanical stretch on cyclooxygenase type 2 expression and activator protein-1 and nuclear factor-kappaB activity in human amnion cells.
    Mohan AR; Sooranna SR; Lindstrom TM; Johnson MR; Bennett PR
    Endocrinology; 2007 Apr; 148(4):1850-7. PubMed ID: 17218407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Oxytocin Analogs.
    Wiśniewski K
    Methods Mol Biol; 2019; 2001():235-271. PubMed ID: 31134574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.